Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m641 · Cited by 727

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Section of Precision Medicine Group of Chinese Society of Cardiology, Wang, D. W., Editorial Board of Chinese Journal of Cardiology, Working Group of Adult Fulminant Myocarditis, Li, S., Jiang, J., Yan, J., Zhao, C., Wang, Y., Ye-xin, M., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9385-3 · Cited by 128

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664

The trinity of COVID-19: immunity, inflammation and intervention

Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360

Extrapulmonary manifestations of COVID-19

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185

An inflammatory cytokine signature predicts COVID-19 severity and survival

Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Cummings, M. J., Baldwin, M. R., Abrams, D. C., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31189-2 · Cited by 2,245

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Püntmann, V. O., Carerj, M. L., Wieters, I., Fahim, M., Arendt, C. T., Hoffmann, J., Shchendrygina, A., Escher, F., Vasa‐Nicotera, M., Zeiher, A. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3557 · Cited by 2,228

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105

Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19

Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J. C., Biondi‐Zoccai, G., Brown, T. S., Der-Nigoghossian, C. A., Zidar, D. A., Haythe, J. H., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,086

Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis

Wu, X., Nethery, R. C., Sabath, M. B., Braun, D., & Dominici, F. (2020) · Science Advances · doi:10.1126/sciadv.abd4049 · Cited by 2,034

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis

Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0369 · Cited by 1,964

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00676-0 · Cited by 1,983

Potential Effects of Coronaviruses on the Cardiovascular System

Madjid, M., Safavi‐Naeini, P., Solomon, S. D., & Vardeny, O. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1286 · Cited by 1,850

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Lippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,741

The COVID-19 Cytokine Storm; What We Know So Far

Ragab, D., Salah-ElDin, H., Taeimah, M., Khattab, R., & Salem, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01446 · Cited by 1,661

Co-infections in people with COVID-19: a systematic review and meta-analysis.

Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.-M., Divatia, J. V., Shrestha, B. R., Arabi, Y. M., Ng, J., Gomersall, C. D., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30161-2 · Cited by 1,509

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Alhazzani, W. A., Møller, M. H., Arabi, Y. M., Loeb, M. B., Gong, M. N., Fan, E., Oczkowski, S. J. W., Levy, M. M., Derde, L. P. G., Dzierba, A. L., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,578

The COVID-19 pandemic

Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,744

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Horby, P., Mafham, M. M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J., Wiselka, M. J., Ustianowski, A., Elmahi, E., Prudon, B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022926 · Cited by 1,481

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Guzik, T. J., MOHIDDIN, S. A., Dimarco, A. D., Patel, V., Savvatis, K., Marelli‐Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D’Acquisto, F., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa106 · Cited by 1,484

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy

Dashraath, P., Wong, J. L. J., Lim, M. X. K., Lim, L. M., Li, S. W. L., Biswas, A., Choolani, M. A., Mattar, C. N. Z., & Su, L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.021 · Cited by 1,521

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,436

COVID‐19 diagnosis and management: a comprehensive review

Pascarella, G., Strumia, A., Piliego, C., Bruno, F., BUONO, R. D., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,435

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Salama, C., Han, J., Yau, L., Reiss, W. G., Krämer, B., Neidhart, J. D., Criner, G. J., Kaplan‐Lewis, E., Baden, R. P., Pandit, L. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2030340 · Cited by 1,306

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266

Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships

Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

Harrison, A. G., Lin, T., & Wang, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.004 · Cited by 1,261

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Gianfrancesco, M. A., Hyrich, K. L., Al-Adely, S., Carmona, L., Danila, M. I., Gossec, L., Izadi, Z., Jacobsohn, L., Katz, P., Lawson‐Tovey, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217871 · Cited by 1,155

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Rosas, I. O., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D. J., Aziz, M. S., Cooper, N., Douglas, I. S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028700 · Cited by 1,141

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Costela-Ruiz, V. J., Montes, R. I., Puerta, J. M., Ruíz, C., & Melguizo‐Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,132

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

Azkur, A. K., Akdiş, M., Azkur, D., Sokołowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K. C., & Akdiş, C. A. (2020) · Allergy · doi:10.1111/all.14364 · Cited by 1,149

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy

Morris, E. C., Neelapu, S. S., Giavridis, T., & Sadelain, M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00547-6 · Cited by 1,187

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group (2021) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · doi:10.17863/cam.70428 · Cited by 1,071

Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility

Chan, J. F., Zhang, J., Yuan, S., Poon, V. K., Chan, C. C., Lee, A. C.-Y., Chan, W.-M., Fan, Z., Tsoi, H.-W., Wen, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa325 · Cited by 1,048

COVID-19 and Multiorgan Response

Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100618 · Cited by 1,054

Cardiovascular complications in COVID-19

Long, B., Brady, W. J., Koyfman, A., & Gottlieb, M. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.04.048 · Cited by 1,012

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Cavalli, G., Luca, G. D. D., Campochiaro, C., Della‐Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Din, C. T., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 988

Cytokines: From Clinical Significance to Quantification

Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 1,015

Considering how biological sex impacts immune responses and COVID-19 outcomes

Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C., & Klein, S. L. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0348-8 · Cited by 954

Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression

Huang, I., Lim, M. A., & Pranata, R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.018 · Cited by 974

Biomarkers associated with COVID-19 disease progression

Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Özben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 920

Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis

Coomes, E. A., & Haghbayan, H. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2141 · Cited by 914

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Leisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V. V., Mastroianni, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 874

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475

Collider bias undermines our understanding of COVID-19 disease risk and severity

Griffith, G. J., Morris, T. T., Tudball, M. J., Herbert, A., Mancano, G., Pike, L., Sharp, G. C., Sterne, J., Palmer, T. M., Davey Smith, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19478-2 · Cited by 826

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Pereira, M. R., Mohan, S., Cohen, D. J., Husain, S. A., Dube, G. K., Ratner, L. E., Arcasoy, S. M., Aversa, M. M., Benvenuto, L. J., Dadhania, D. M., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15941 · Cited by 815

Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management

Siripanthong, B., Nazarian, S., Muser, D., Deo, R., Santangeli, P., Khanji, M. Y., Cooper, L. T., & Chahal, C. A. A. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.001 · Cited by 808

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N. K., Singla, V., Khare, S., & Srivastava, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.044 · Cited by 814

Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives

Kaye, A. D., Okeagu, C. N., Pham, A. D., Silva, R. A., Hurley, J. J., Arron, B. L., Sarfraz, N., Lee, H. N., Ghali, G. E., Gamble, J. W., et al. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.11.009 · Cited by 777

Industry 4.0 technologies and their applications in fighting COVID-19 pandemic

Javaid, M., Haleem, A., Vaishya, R., Bahl, S., Suman, R., & Vaish, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.032 · Cited by 758

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.6820 · Cited by 734

The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

Bonanad, C., García-Blas, S., Tarazona-Santabalbina, F., Sanchis, J., Bertomeu-González, V., Fácila, L., Ariza, A., Núñez, J., & Cordero, A. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.05.045 · Cited by 730

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Marconi, V. C., Ramanan, A. V., de Bono, S., Kartman, C. E., Krishnan, V., Liao, R., Piruzeli, M. L. B., Goldman, J. D., Alatorre-Alexander, J., Pellegrini, R. D. C., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00331-3 · Cited by 764

Comprehensive mapping of immune perturbations associated with severe COVID-19

Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd7114 · Cited by 723

Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality

Zhang, J., Dong, X., Liu, G., & Gao, Y. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 782

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis

Lippi, G., Lavie, C. J., & Sanchis‐Gomar, F. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.03.001 · Cited by 738

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662

COVID-19 and the Heart

Akhmerov, A., & Marbán, E. (2020) · Circulation Research · doi:10.1161/circresaha.120.317055 · Cited by 700

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

Nadim, M. K., Forni, L. G., Mehta, R. L., Connor, M. J., Jr., Liu, K. D., Ostermann, M., Rimmele, T. R., Zarbock, A., Bell, S., Bihorac, A., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00356-5 · Cited by 701

The role of biomarkers in diagnosis of COVID-19 – A systematic review

Kermali, M., Khalsa, R. K., Pillai, K., Ismail, Z., & Harky, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117788 · Cited by 689

COVID-19: Immunology and treatment options

Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 687

Association of inflammatory markers with the severity of COVID-19: A meta-analysis

Zeng, F., Huang, Y., Guo, Y., Yin, M., Chen, X., Liang, X., & Deng, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.055 · Cited by 676

Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

Izcovich, A., Ragusa, M. A., Tortosa, F. G., Marzio, M. A. L., Agnoletti, C., Bengolea, A., Ceirano, A., Espinosa, F., Saavedra, E., Sanguine, V., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241955 · Cited by 676

Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China

Song, G., Liang, G., & Liu, W. (2020) · Mycopathologia · doi:10.1007/s11046-020-00462-9 · Cited by 662

Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting

Hughes, S., Troise, O., Donaldson, H., Mughal, N., & Moore, L. S. P. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.025 · Cited by 645

Anakinra for severe forms of COVID-19: a cohort study

Huet, T., Beaussier, H., Voisin, O., Jouveshomme, S., Dauriat, G., Lazareth, I., Sacco, E., Naccache, J., Bézie, Y., Laplanche, S., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30164-8 · Cited by 652

Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis

Tian, W., Jiang, W., Yao, J., Nicholson, C., Li, R., Sigurslid, H. H., Wooster, L. T., Rotter, J. I., Guo, X., & Malhotra, R. K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26050 · Cited by 662

Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection

Messner, C. B., Demichev, V., Wendisch, D., Michalick, L., White, M., Freiwald, A., Textoris-Taube, K., Vernardis, S. I., Egger, A.-S., Kreidl, M., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.05.012 · Cited by 561

The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study

Hewitt, J., Carter, B., Vilches‐Moraga, A., Quinn, T. J., Braude, P., Verduri, A., Pearce, L., Stechman, M., Short, R., Price, A., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30146-8 · Cited by 632

Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis

Malik, P., Patel, U. K., Mehta, D., Patel, N., Kelkar, R., Akrmah, M., Gabrilove, J. L., & Sacks, H. S. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111536 · Cited by 618

Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China

Chen, R., Liang, W., Jiang, M., Guan, W., Zhan, C., Wang, T., Tang, C., Sang, L., Liu, J., Ni, Z., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.010 · Cited by 619

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Henry, B. M., Aggarwal, G., Wong, J., Benoit, S. W., Vikse, J., Plebani, M., & Lippi, G. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.05.073 · Cited by 626

The signal pathways and treatment of cytokine storm in COVID-19

Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 618

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis

Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620937175 · Cited by 630

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome

Hendren, N. S., Drazner, M. H., Bozkurt, B., & Cooper, L. T. (2020) · Circulation · doi:10.1161/circulationaha.120.047349 · Cited by 576

Mild versus severe COVID-19: Laboratory markers

Velavan, T. P., & Meyer, C. G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.061 · Cited by 589

C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early

Tan, C., Huang, Y., Shi, F., Tan, K., Ma, Q., Chen, Y., Jiang, X., & Li, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25871 · Cited by 568

Nutrition, immunity and COVID-19

Calder, P. C. (2020) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000085 · Cited by 612

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy

Nicolai, L., Leunig, A., Brambs, S., Kaiser, R. W. J., Weinberger, T., Weigand, M., Muenchhoff, M., Hellmuth, J. C., Ledderose, S., Schulz, H., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048488 · Cited by 573

The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions

Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 590

Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

Booth, A., Reed, A. B., Ponzo, S., Yassaee, A., Aral, M., Plans, D., Labrique, A. B., & Mohan, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247461 · Cited by 582

The unique characteristics of COVID-19 coagulopathy

Iba, T., Levy, J. H., Connors, J. M., Warkentin, T. E., Thachil, J. V., & Levi, M. M. (2020) · Critical Care · doi:10.1186/s13054-020-03077-0 · Cited by 548

Immunopathology of Hyperinflammation in COVID-19

Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abaleke, E., Abbas, M. A., Abbasi, S., Abbott, A., Abdelaziz, A., Abdelbadiee, S., Abdelfattah, M., Abdul, B., Rasheed, A. A., Kadir, R. A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00149-5 · Cited by 561

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar‐Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M. W., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 528

Clinical considerations for patients with diabetes in times of COVID-19 epidemic

Gupta, R., Ghosh, A., Singh, A. K., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.002 · Cited by 522

The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection

Pons, S., Fodil, S., Azoulay, É., & Zafrani, L. (2020) · Critical Care · doi:10.1186/s13054-020-03062-7 · Cited by 532

Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

Bhaskar, S. M. M., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 524

Organ-specific manifestations of COVID-19 infection

Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis‐Stathopoulos, I., Ψαλτοπούλου, Θ., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00648-x · Cited by 501

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Somers, E. C., Eschenauer, G. A., Troost, J. P., Golob, J. L., Gandhi, T. N., Wang, L., Zhou, N., Petty, L. A., Baang, J. H., Dillman, N. O., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa954 · Cited by 505

The SARS-CoV-2 as an instrumental trigger of autoimmunity

Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., & Shoenfeld, Y. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102792 · Cited by 510

Myocardial injury and COVID-19: Possible mechanisms

Babapoor-Farrokhran, S., Gill, D., Walker, J., Rasekhi, R. T., Bozorgnia, B., & Amanullah, A. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117723 · Cited by 493

Relative Lymphocytosis in COVID-19—A Ray of Hope

Ish, P., Malhotra, N., Agrawal, S. P., & Gupta, N. (2020) · Advances in respiratory medicine · doi:10.5603/arm.a2020.0098 · Cited by 11

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Wang, K., Zhang, Z., Yu, M., Tao, Y., & Xie, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06047-w · Cited by 87

Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective StudyPreprint

Zhang, S., Guo, M., Duan, L., Wu, F., Wang, Z., Xu, J., Ma, Y., Lv, Z., Tan, X., Zhang, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551390 · Cited by 8

“Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.” Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng and Huan-Zhong Shi. Eur Respir J 2020; 55: 2000524.

European Respiratory Society (2020) · European Respiratory Journal · doi:10.1183/13993003.50524-2020 · Cited by 18

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su, M., Yuan, J., Peng, J., Wu, M., Yang, Y., & Peng, Y. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.109927 · Cited by 5